Fig. 1From: De novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudineGenetic analysis of multidrug-resistant strains (135 clones) from patients receiving nucleoside/nucleotide analogue treatment. The expanded sections show de novo entecavir resistance mutationsBack to article page